FDA Approves Targeted Immunotherapy for Aggressive Forms of Follicular Lymphoma Thumbnail Image Read more about FDA Approves Targeted Immunotherapy for Aggressive Forms of Follicular Lymphoma
FDA Approves Immunotherapy for Earlier Use in B-cell Acute Lymphoblastic Leukemia Thumbnail Image Read more about FDA Approves Immunotherapy for Earlier Use in B-cell Acute Lymphoblastic Leukemia
FDA Approves a New Immune-Based Treatment Option for People with Mantle Cell Lymphoma Thumbnail Image Read more about FDA Approves a New Immune-Based Treatment Option for People with Mantle Cell Lymphoma
FDA’s Recent Approval of 2 CAR T-Cell Therapies a ‘Big Step Toward’ Long-Term Control of Myeloma for More Patients Thumbnail Image Read more about FDA’s Recent Approval of 2 CAR T-Cell Therapies a ‘Big Step Toward’ Long-Term Control of Myeloma for More Patients
FDA Expands Use of Leukemia Treatment to Include Children Thumbnail Image Read more about FDA Expands Use of Leukemia Treatment to Include Children
FDA Approves First Ever BTK Inhibitor to Treat Lymphoma Subtype Thumbnail Image Read more about FDA Approves First Ever BTK Inhibitor to Treat Lymphoma Subtype
Recent FDA Approval a ‘Great Step in the Right Direction’ for Improving Quality of Life in Blood Cancer Patients Thumbnail Image Read more about Recent FDA Approval a ‘Great Step in the Right Direction’ for Improving Quality of Life in Blood Cancer Patients
Latest FDA Approval in Multiple Myeloma May Reduce Treatment Costs, Frequency and Side Effects Thumbnail Image Read more about Latest FDA Approval in Multiple Myeloma May Reduce Treatment Costs, Frequency and Side Effects
FDA Approves New Drug for the Most Common Form of Leukemia in Adults Thumbnail Image Read more about FDA Approves New Drug for the Most Common Form of Leukemia in Adults
FDA Approves Drug Designed to Target Specific Mutation in Rare Blood Cancer Type Thumbnail Image Read more about FDA Approves Drug Designed to Target Specific Mutation in Rare Blood Cancer Type
